Wells Fargo’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.53M | Sell |
102,999
-13,312
| -11% | -$315K | ﹤0.01% | 3092 |
|
|
2025
Q4 | $2.89M | Buy |
116,311
+58,134
| +100% | +$1.54M | ﹤0.01% | 3146 |
|
|
2025
Q3 | $1.65M | Buy |
58,177
+26,879
| +86% | +$728K | ﹤0.01% | 3456 |
|
|
2025
Q2 | $779K | Buy |
31,298
+1,573
| +5% | +$44.3K | ﹤0.01% | 3851 |
|
|
2025
Q1 | $922K | Buy |
29,725
+7,241
| +32% | +$241K | ﹤0.01% | 3697 |
|
|
2024
Q4 | $709K | Buy |
22,484
+6,596
| +42% | +$313K | ﹤0.01% | 3949 |
|
|
2024
Q3 | $921K | Sell |
15,888
-248
| -2% | -$12.2K | ﹤0.01% | 3595 |
|
|
2024
Q2 | $654K | Buy |
16,136
+515
| +3% | +$20.4K | ﹤0.01% | 3739 |
|
|
2024
Q1 | $656K | Buy |
15,621
+1,786
| +13% | +$69.7K | ﹤0.01% | 3713 |
|
|
2023
Q4 | $530K | Buy |
13,835
+2,564
| +23% | +$85.4K | ﹤0.01% | 3828 |
|
|
2023
Q3 | $348K | Sell |
11,271
-11,471
| -50% | -$396K | ﹤0.01% | 4006 |
|
|
2023
Q2 | $719K | Buy |
22,742
+10,601
| +87% | +$364K | ﹤0.01% | 3689 |
|
|
2023
Q1 | $443K | Buy |
12,141
+8,169
| +206% | +$286K | ﹤0.01% | 3930 |
|
|
2022
Q4 | $118K | Sell |
3,972
-1,490
| -27% | -$47.9K | ﹤0.01% | 4457 |
|
|
2022
Q3 | $213K | Sell |
5,462
-164
| -3% | -$7.51K | ﹤0.01% | 4215 |
|
|
2022
Q2 | $217K | Sell |
5,626
-24,343
| -81% | -$926K | ﹤0.01% | 4233 |
|
|
2022
Q1 | $1.45M | Sell |
29,969
-20,266
| -40% | -$1.05M | ﹤0.01% | 3577 |
|
|
2021
Q4 | $3.69M | Buy |
50,235
+2,568
| +5% | +$211K | ﹤0.01% | 2876 |
|
|
2021
Q3 | $4.34M | Buy |
47,667
+14,241
| +43% | +$1.21M | ﹤0.01% | 2968 |
|
|
2021
Q2 | $2.1M | Buy |
33,426
+10,510
| +46% | +$389K | ﹤0.01% | 3649 |
|
|
2021
Q1 | $621K | Sell |
22,916
-24,717
| -52% | -$595K | ﹤0.01% | 4571 |
|
|
2020
Q4 | $871K | Sell |
47,633
-6,662
| -12% | -$120K | ﹤0.01% | 4131 |
|
|
2020
Q3 | $974K | Buy |
54,295
+5,958
| +12% | +$103K | ﹤0.01% | 3881 |
|
|
2020
Q2 | $797K | Buy |
48,337
+27,696
| +134% | +$436K | ﹤0.01% | 3991 |
|
|
2020
Q1 | $267K | Sell |
20,641
-7,072
| -26% | -$115K | ﹤0.01% | 4488 |
|
|
2019
Q4 | $510K | Sell |
27,713
-26,414
| -49% | -$438K | ﹤0.01% | 4348 |
|
|
2019
Q3 | $954K | Buy |
54,127
+21,405
| +65% | +$366K | ﹤0.01% | 3876 |
|
|
2019
Q2 | $547K | Buy |
32,722
+6,215
| +23% | +$113K | ﹤0.01% | 4324 |
|
|
2019
Q1 | $486K | Sell |
26,507
-7,769
| -23% | -$149K | ﹤0.01% | 4350 |
|
|
2018
Q4 | $680K | Buy |
34,276
+3,368
| +11% | +$63K | ﹤0.01% | 4130 |
|
|
2018
Q3 | $682K | Sell |
30,908
-803
| -3% | -$16.9K | ﹤0.01% | 4234 |
|
|
2018
Q2 | $820K | Buy |
+31,711
| New | +$543K | ﹤0.01% | 4126 |
|
Other funds holding ASTH
VPM
3C
VCM
6CM
Wells Fargo's ASTH Position: Q1 2026 in Review
Wells Fargo reduced its Astrana Health (ASTH) stake by 11% in Q1 2026, selling an estimated $315K and leaving 102,999 shares worth $2.53M. The position accounts for ﹤0.01% of the portfolio, ranked #3092.
Wells Fargo first reported a position in ASTH in Q2 2018 and has held it in 32 quarters since. The position peaked at $4.34M in Q3 2021. 171 funds tracked by Wall St. Rank hold ASTH as of Q1 2026.
- Wells Fargo held 102,999 shares of Astrana Health worth $2.53M as of Q1 2026.
- Wells Fargo sold 13,312 Astrana Health shares in Q1 2026, an estimated $315K.
- Astrana Health made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #3092 holding.
- Wells Fargo first reported a position in Astrana Health in Q2 2018 and has held it in 32 quarters since.
- Wells Fargo's Astrana Health position peaked at $4.34M in Q3 2021.
- 171 funds tracked by Wall St. Rank held Astrana Health as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.